The World Health Organization (WHO) has raised an alarm about the escalating threat of antimicrobial resistance (AMR), projecting that it could claim 39 million lives by 2050 if urgent global action is not taken.
This was revealed by WHO Director-General Dr. Tedros Adhanom Ghebreyesus at the Fourth Global High-Level Ministerial Conference on Antimicrobial Resistance (AMR) in Saudi Arabia recently.
Ghebreyesus stressed the immediate threat posed by AMR and the urgent need for global action to combat it.
“The same is true of antimicrobial resistance,” Dr. Tedros said, drawing a parallel to the urgency of addressing climate change. “AMR doesn’t just threaten to make the medicines on which we depend less effective; it’s happening now. We’re not just talking about the risk of people dying from antibiotic-resistant infections; they’re dying now – 1.3 million people every year.”
Dr. Tedros emphasized that tackling AMR action is equally as urgent as climate action. He referenced the Political Declaration on AMR adopted at this year’s UN General Assembly, noting its ambitious goals to mitigate the impact of bacterial AMR.
Read Also: MPOX: WHO Approves Bavarian Nordic’s Jynneos Vaccine For Adolescents
“The political declaration agreed at the General Assembly set clear targets for prevention, diagnosis, treatment, and financing, which should ultimately reduce deaths from bacterial AMR by 10 percent by 2030,” Dr. Tedros stated.
The WHO Director-General called on governments, stakeholders, and the international community to work collaboratively to translate commitments into action, ensuring that lives are saved, and the effectiveness of life-saving medicines is preserved for future generations.
Key priorities for implementing the political declaration on AMR
Ghebreyesus highlighted three major priorities for implementing the Political Declaration on AMR, especially in low- and middle-income countries.
Dr. Tedros emphasized the need for sustainable financing, urging both domestic and international sources to invest in AMR responses. “I urge Member States and development partners to join the AMR Multi-Partner Trust Fund, as called for in the Declaration,” he said.
Read Also: Mpox Outbreak: Brazzaville Hosts WHO Regional Meeting
With a modest target of US$100 million, Dr. Tedros called for greater financial resources to fund national action plans, aiming for 60% of countries to have these plans in place.
The WHO head also stressed the importance of equitable access to quality antimicrobials, noting the paradox of AMR: inappropriate use contributes to resistance, while many also suffer due to lack of access. “Addressing AMR means increasing access for those who need them while preventing the overuse and misuse that drives antimicrobial resistance,” he said.
Lastly, Dr. Tedros highlighted the urgent need for research, development, and innovation to address the “dry antimicrobial pipeline.” He pointed to the SECURE initiative, a global effort led by WHO and the Global Antibiotic Research and Development Partnership (GARD-P), as an essential step in improving access to both new and existing antimicrobials.
“The threat of AMR is right here and right now, but so are the solutions,” Dr. Tedros concluded. “Let us seize this opportunity to accelerate action on AMR, commit to stronger collaboration, and protect the medicines that protect us.”